Country | AFG | LKA | TZA | ETH | FJI | ARG | MDA |
---|---|---|---|---|---|---|---|
Tympanic membrane characteristics (contour, colour, translucency) | + | + | + | + | + | + | + |
Otorrhoea | +/− | + | +/− | +/− | + | +/− | + |
Fever | + | + | + | + | − | + | + |
Otalgia | + | + | + | + | − | + | + |
Use of pneumatic otoscopy (mobility) | − | + | − | − | − | + | +* |
Use of tympanometry | − | − | − | − | − | − | +* |
Hearing loss, dizziness | − | − | + | − | − | − | +* |
*Use of pneumatic otoscopy/tympanometry and concern for hearing loss in the 2011 guidelines only.
AFG, Afghanistan; ARG, Argentina; ETH, Ethiopia; FJI, Fiji; LKA, Sri Lanka; MDA, Moldova; TZA, Tanzania.